Alexion Pharmaceuticals Inc. should provide information on research and manufacturing costs for its Soliris rare-disease drug to help justify a price of 340,200 pounds a year ($569,000), the U.K.’s health-cost agency said.
In 1785, the caricaturist Henry William Bunbury declared strong drink, aided by a demon, as the cause of the painful inflammatory disease known as gout. Two hundred years later, AstraZeneca Plc may be on the verge of winning approval for a more effective treatment for the malady.
People with a one in 10 chance of heart or circulatory diseases in the next decade should take cholesterol-lowering drugs and change their diet and alcohol intake, exercise more and stop smoking, new U.K. guidelines say.
Britain’s National Health Service will need another overhaul in five years if “damaging” changes being implemented by the government are allowed to continue, the editors of three U.K. health-care publications said.
The U.K.’s National Health Service will have an oversupply of as many as 20,000 doctors by the end of the decade, pressuring medical professionals to accept lower- paid roles or seek work abroad, the Financial Times said.